Patrick Weiss
Director/Board Member chez Scale Biosciences, Inc.
Profil
Patrick Weiss joined ARCH as a Venture Partner in 2022.
In this capacity Patrick is focused on identifying and evaluating new breakthrough life science technologies.
He also assists in creating, scaling and operating ARCH portfolio companies.
Patrick joins ARCH from Twist Bioscience, a company providing synthetic DNA-based products based on a disruptive and proprietary technology, including synthetic genes, tools for NGS sample preparation, and antibody libraries for drug discovery and development.
During his tenure as COO, he played a pivotal role in navigating Twist from a small pre–Series A start-up to a successful publicly traded company.
Prior to Twist he was the CEO of Operon Biotechnologies, a global leader in nucleic acid synthesis, sequencing and bio-informatics services, Vice President Gene silencing at Qiagen responsible for its RNA synthesis and siRNA product portfolio and Founder and CEO of Xeragon Inc., a global leader in RNA synthesis and related products.
He currently serves on the board of Slingshot Biosciences and Scale Biosciences.
Patrick holds a MSc ETH from the Swiss Federal Institute of Technology in Organic Chemistry and Economics and is inventor on several patents and publications in the field of nucleic acid synthesis and related fields.
Postes actifs de Patrick Weiss
| Sociétés | Poste | Début |
|---|---|---|
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Private Equity Investor | 01/11/2022 |
Slingshot Biosciences, Inc.
 Slingshot Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Slingshot Biosciences, Inc. is a life sciences company that develops synthetic cells for various applications in diagnostics and therapeutics. The company is based in Emeryville, CA. The company utilizes advances in distributed manufacturing, engineering, and polymer chemistry to provide an industry-first, off-the-shelf solution for cell-like reagents that are stable, low-cost, and targeted towards a range of indications and markets. Slingshot Biosciences focuses on developing cutting-edge tools for fluorescence imaging to revolutionize how scientists explore and understand the intricate mechanisms of life. The company is committed to empowering researchers with exceptional products that enable groundbreaking discoveries and shape the future of bioscience. The company was founded in 2012 by Jeffrey Kim, who has been the CEO since 2012. | Director/Board Member | 01/04/2022 |
Scale Biosciences, Inc.
 Scale Biosciences, Inc. Medical SpecialtiesHealth Technology Scale Biosciences, Inc. is an American single-cell sequencing solutions company that aims to unlock the potential of single-cell analysis at scale by eliminating barriers to discovery. The private company has R & D facilities in Menlo Park, CA and another location that is not specified. The company is located in the US. Scalebio is financed by leading life sciences tools investors Arch Venture Partners, BNG, and Tao Capital. The company's multidisciplinary team of scientists and technologists has combined expertise in next-generation sequencing, genomics, proteomics, and bioinformatics. Discover how their single-cell sequencing technology enables scalable sample indexing, cell throughput, and multi-omics analysis. | Director/Board Member | - |
Anciens postes connus de Patrick Weiss
| Sociétés | Poste | Fin |
|---|---|---|
| TWIST BIOSCIENCE CORPORATION | Chief Operating Officer | 21/04/2022 |
Eurofins Genomics LLC
 Eurofins Genomics LLC Pharmaceuticals: MajorHealth Technology Eurofins Genomics LLC engages in the provision of genomic products and services. It offers deoxyribonucleic acid (DNA) sequencing, gene synthesis, and bioinformatics services for academic and industrial research. The company was founded in 1990 and is headquartered in Louisville, KY. | Chief Executive Officer | 01/03/2010 |
Qiagen, Inc.
 Qiagen, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen, Inc. provided technologies for separating, purifying and handling nucleic acids. The company was founded in 1988 and was headquartered in Germantown, MD. | Founder | 01/06/2004 |
Xeragon, Inc.
 Xeragon, Inc. Miscellaneous Commercial ServicesCommercial Services Xeragon, Inc. is a company that researches and develops DNA and RNA products. The company is based in Huntsville, AL. The company was founded by Patrick Weiss. Xeragon was acquired by QIAGEN NV on April 18, 2002 for $9.35 million. | Founder | 01/04/2002 |
Formation de Patrick Weiss
| Swiss Federal Institute of Technology | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TWIST BIOSCIENCE CORPORATION | Health Technology |
| Entreprise privées | 6 |
|---|---|
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Finance |
Xeragon, Inc.
Xeragon, Inc. Miscellaneous Commercial ServicesCommercial Services Xeragon, Inc. is a company that researches and develops DNA and RNA products. The company is based in Huntsville, AL. The company was founded by Patrick Weiss. Xeragon was acquired by QIAGEN NV on April 18, 2002 for $9.35 million. | Commercial Services |
Qiagen, Inc.
Qiagen, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen, Inc. provided technologies for separating, purifying and handling nucleic acids. The company was founded in 1988 and was headquartered in Germantown, MD. | Commercial Services |
Eurofins Genomics LLC
Eurofins Genomics LLC Pharmaceuticals: MajorHealth Technology Eurofins Genomics LLC engages in the provision of genomic products and services. It offers deoxyribonucleic acid (DNA) sequencing, gene synthesis, and bioinformatics services for academic and industrial research. The company was founded in 1990 and is headquartered in Louisville, KY. | Health Technology |
Slingshot Biosciences, Inc.
Slingshot Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Slingshot Biosciences, Inc. is a life sciences company that develops synthetic cells for various applications in diagnostics and therapeutics. The company is based in Emeryville, CA. The company utilizes advances in distributed manufacturing, engineering, and polymer chemistry to provide an industry-first, off-the-shelf solution for cell-like reagents that are stable, low-cost, and targeted towards a range of indications and markets. Slingshot Biosciences focuses on developing cutting-edge tools for fluorescence imaging to revolutionize how scientists explore and understand the intricate mechanisms of life. The company is committed to empowering researchers with exceptional products that enable groundbreaking discoveries and shape the future of bioscience. The company was founded in 2012 by Jeffrey Kim, who has been the CEO since 2012. | Commercial Services |
Scale Biosciences, Inc.
Scale Biosciences, Inc. Medical SpecialtiesHealth Technology Scale Biosciences, Inc. is an American single-cell sequencing solutions company that aims to unlock the potential of single-cell analysis at scale by eliminating barriers to discovery. The private company has R & D facilities in Menlo Park, CA and another location that is not specified. The company is located in the US. Scalebio is financed by leading life sciences tools investors Arch Venture Partners, BNG, and Tao Capital. The company's multidisciplinary team of scientists and technologists has combined expertise in next-generation sequencing, genomics, proteomics, and bioinformatics. Discover how their single-cell sequencing technology enables scalable sample indexing, cell throughput, and multi-omics analysis. | Health Technology |
